Erythrocytosis Due to Phd2 Mutation
📧 Sign up to get email alerts when something new happens for Erythrocytosis Due to Phd2 Mutation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-09-20Clinical Trial Update: Digoxin for Congenital Erythrocytosis Due to Up-Regulated Hypoxia Sensing [Phase 1]
A Phase 1 clinical trial investigating digoxin for congenital erythrocytosis linked to up-regulated hypoxia sensing has been withdrawn.